Gastrin, CCK, signaling, and cancer

Annual Review of Physiology

Volumn 63, Issue , 2001, Pages 49-76

  Rozengurt, E ^a   Walsh, J H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE; GASTRIN; GASTRIN RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; LOXTIDINE; MITOGEN ACTIVATED PROTEIN KINASE; OMEPRAZOLE; PAXILLIN; PHOSPHATIDYLINOSITOL; PROTEIN KINASE C; PROTEIN P130; PROTEIN TYROSINE KINASE; PROTON PUMP INHIBITOR; RANITIDINE;

ASTROCYTOMA; ATROPHIC GASTRITIS; CANCER; CARCINOID; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; ENTEROCHROMAFFIN CELL; GASTRIN CELL; GASTRINOMA; GENE EXPRESSION; HUMAN; HYPERGASTRINEMIA; LUNG SMALL CELL CANCER; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH MUCOSA; STOMACH PARIETAL CELL; THYROID MEDULLARY CARCINOMA; ZOLLINGER ELLISON SYNDROME;

ANIMALS; CHOLECYSTOKININ; GASTRINS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0035043906     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.63.1.49     Document Type: Review

References (168)

1. Gastrin
2. The mechanism of histamine secretion from gastric enterochromaffin-like cells
3. Physiology of isolated gastric endocrine cells
4. Intracellular signaling mechanisms activated by cholecystokinin regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells
5. Gastrin and gastric enterochromaffin-like cell carcinoids in the rat
6. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis
7. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract
8. Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice
9. Gastrin and colorectal cancer: A prospective study
10. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
11. Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa
12. Identification of progastrin derived peptides in colorectal carcinoma extracts
13. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines
14. Gastrin, gastrin receptors and colorectal carcinoma
15. The gastrins: Their production and biological activities
16. Identification of progastrin in gastrinomas, antrum, and duodenum by a novel radioimmunoassay
17. Carboxyl terminal glycine extended progastrin (gastrin-G) in gastric antral mucosa of patients with gastric or duodenal ulcer and in gastrinomas
18. Purification and structural characterization of progastrin-derived peptides from a human gastrinoma
19. Biological activity of carboxy-terminal gastrin analogs
20. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
21. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings
22. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids
23. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa
24. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy
25. Pathophysiological effects of long-term acid suppression in man
26. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
27. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat
28. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats
29. Toxicological studies on omeprazole
30. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats
31. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffin-like cell carcinoids in the rat
32. Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine
33. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria
34. CCK2 receptor antagonists: Pharmacological tools to study the gastrin-ECL cell-parietal cell axis
35. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression
36. Gastrinmediates the gastric mucosal proliferative response to feeding
37. Gastrin mediates the increase in gastric cell growth in uremic rats
38. The gastric enterochromaffin-like cell: An enigmatic cellular link
39. The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: A study with the specific gastrin receptor antagonist AG041R
40. Interspecies polymorphisms confer constitutive activity to the Mastomys cholecystokinin-B/gastrin receptor
41. Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole
42. Gastrin stimulates the growth of gastric pit with less-differentiated features
43. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer
44. Processing and proliferative effects of human progastrin in transgenic mice
45. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation
46. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM
47. Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour
48. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice
49. Impaired gastric acid secretion in gastrin-deficient mice
50. Lessons from genetically engineered animal models. III. Lessons learned from gastrin gene deletion in mice
51. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo
52. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptordeficient mice
53. Induction of heparin binding epidermal growth factor-like growth factor and amphiregulin mRNAs by gastrin in the rat stomach
54. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor
55. Multiple endocrine neoplasia type 1: Clinical and genetic features of the hereditary endocrine neoplasias
56. Reg gene expression is increased in rat gastric enterochromaffin-like cells following water immersion stress
57. Mutations of RegI alpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia
58. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids
59. Topical review, gastrin and gastric epithelial physiology
60. Signaling pathways mediating gastrin's growth-promoting effects
61. Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP
62. The human CCKB/gastrin receptor transfected into rat1 fibroblasts mediates activation of MAP kinase, p74raf-1 kinase, and mitogenesis
63. Functional characterization of a human brain cholecystokinin-B receptor. Atrophic effect of cholecystokinin and gastrin
64. Correlation between Ca(2+) oscillation and cell proliferation via CCK(B)/gastrin receptor
65. 2+ mobilization and clonal growth in small cell lung cancer cells
66. 2+ mobilization and clonal growth
67. 2+ mobilization and clonal growth in small cell lung cancer through CCKA and CCKB/gastrin receptors
68. Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human
69. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells
70. Molecular mechanisms for the growth factor action of gastrin
71. Cell typespecific requirement of the MAPK pathway for the growth factor action of gastrin
72. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors
73. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells
74. G protein-coupled receptors. I. Diversity of receptor-ligand interactions
75. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: An exemplary family
76. Early signals in the mitogenic response
77. Neuropeptides as cellular growth factors: Role of multiple signalling pathways
78. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists
79. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins
80. 2+ signaling
81. 2+-signalling patterns by NAADP in pancreatic acinar cells
82. Early signalling mechanism in colonic epithelial cell response to gastrin
83. Calcium oscillations increase the efficiency and specificity of gene expression
84. 2+ spike frequency can optimize gene expression
85. Protein kinase C and lipid signaling for sustained cellular responses
86. 2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation
87. Molecular cloning and characterization of protein kinase D: A target for diacylglycerol and phorbol esters with a distinctive catalytic domain
88. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway
89. Bombesin, vasopressin, endothelin, bradykinin, and plateletderived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway
90. Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q)
91. Protein kinase D (PKD) activation is a novel early event in CCKB/gastrin receptor signaling
92. Arachidonic-acid-selective cytosolic phospholipase A2 is involved in gastrin-induced AR4-2J-cell proliferation
93. Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells
94. The cholecystokinin-B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins
95. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells
96. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
97. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades
98. Gastrin induces c-fos gene transcription via multiple signaling pathways
99. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells
100. Comparison of the signal transduction pathways activated by gastrin in enterochromaffin-like and parietal cells
101. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase
102. G Protein-coupled receptors. III. New roles for receptor kinases and B-arrestins in receptor signaling and desensitization
103. Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase
104. Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis
105. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
106. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase
107. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C
108. Gastrin induces tyrosine phosphorylation of Shc proteins and their association with the Grb2/Sos complex
109. βγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation
110. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase
111. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors
112. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways
113. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
114. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway
115. Signal characteristics of G protein-transactivated EGF receptor
116. Role of transactivation of the EGF receptor in signalling by G-proteincoupled receptors
117. Signaling through focal adhesion kinase
118. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding
119. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner
120. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins
121. Cholecystokinin-B/gastrin receptors mediate rapid formation of actin stress fibers
122. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N
123. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
124. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton
125. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase
126. Cooperation between mDial and ROCK in Rho-induced actin reorganization
127. 2+-independent contraction of smooth muscle
128. Regulation of myosin phosphatase by Rho and Rho-associated kinase Rho-kinase
129. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells
130. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation
131. Focal adhesions, contractility, and signaling
132. Tyrosine phosphorylation in the action of neuropeptides and growth factors
133. G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly
134. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho
135. Gα12 and Gα13 stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130 Crk-associated substrate
136. p115 RhoGEF, a GTPase activating protein for Gα12 and Gα13
137. Direct stimulation of the guanine nucleotide exchange activity of p115RhoGEF by Gα13
138. Protein modules and signalling networks
139. SH2- and SH3-mediated interactions between focal adhesion kinase and Src
140. Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells
141. Gastrin stimulates the formation of a p60Src/p 125FAK complex upstream of the phosphatidylinositol 3-kinase signaling pathway
142. TOR signalling and control of cell growth
143. Wortmannin-sensitive activation of p70S6-kinase and MAP-kinase by the G protein-coupled receptor, G/CCKB
144. The CCKB/gastrin receptor is coupled to the regulation of enzyme secretion, protein synthesis and p70 S6 kinase activity in acinar cells from ElasCCKB transgenic mice
145. 2+ mobilization, and the actin cytoskeleton
146. Bombesin, bradykinin, vasopressin, and phorbol esters rapidly and transiently activate Src family tyrosine kinases in Swiss 3T3 cells. Dissociation from tyrosine phosphorylation of p125 focal adhesion kinase
147. 3 formation through phospholipase C gamma 1 and p60c-src kinase
148. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions
149. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation
150. Comparison of the signal transduction pathways activated by gastrin in enterochromaffin-like and parietal cells
151. Regulation of transcription by MAP kinase cascades
152. Rho GTPases
153. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF
154. Ga (13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter
155. Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA
156. Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer
157. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: Effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin
158. Cholecystokinin (CCK)-A and CCKB/gastrin receptors in human tumors
159. Targeting of cholecystokinin-B/gastrin receptors in vivo: Preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin
160. Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential
161. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth
162. Human pancreatic cancer cell lines express the CCKB receptor
163. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion
164. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines
165. Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells
166. The retinoblastoma protein pathway and the restriction point
167. Inhibitors of mammalian G1 cyclin-dependent kinases
168. Control of the G1/S transition